It recently came to my attention that communication within the U.S. Food and Drug Administration (FDA) evidences the Gold Standard agency’s explicit involvement in the Ivermectin disinformation war. While the agency approves ivermectin as an anti-parasite medicine, physicians have increasingly embraced it as an off-label treatment for early-onset COVID-19. Over 60 studies around the world have, for the most part, found positive findings; however, the mainstream media embraced the handful that are neutral or had data problems, for example. Regardless of position, a disinformation campaign was initiated by the FDA and others to deter the use of the off-label treatment. READ the full story: https://trialsitenews.com/fdas-smoking-gun-disinformation-campaign-targeting-ivermectin/